Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PI3K/mTOR Inhibitor-1 | Login | PI3K/mTOR Inhibitor-1 | ||||||||||||||||
|
||||||||||||||||||
| MSA-2 | Login | MSA-2 | ||||||||||||||||
|
||||||||||||||||||
| MSA-2 | Login | MSA-2 | ||||||||||||||||
|
||||||||||||||||||
| PSMA-617 | Login | PSMA-617 | ||||||||||||||||
|
||||||||||||||||||
| PSMA-617 | Login | PSMA-617 | ||||||||||||||||
|
||||||||||||||||||
| MMP-7 Fluorogenic Substrate | Login | MMP-7 Fluorogenic Substrate | ||||||||||||||||
|
||||||||||||||||||
| MMP-2/MMP-9 Fluorogenic Substrate I | Login | MMP-2/MMP-9 Fluorogenic Substrate I | ||||||||||||||||
|
||||||||||||||||||
| BIBR 1087 SE (Desethyl Dabigatran Etexilate) | Login | BIBR 1087 SE (Desethyl Dabigatran Etexilate) | ||||||||||||||||
|
||||||||||||||||||
| BIBR 1087 SE (Desethyl Dabigatran Etexilate) | Login | BIBR 1087 SE (Desethyl Dabigatran Etexilate) | ||||||||||||||||
|
||||||||||||||||||
| PSMA-617 | Login | PSMA-617 | ||||||||||||||||
|
||||||||||||||||||
| BIBR 1087 SE (Desethyl Dabigatran Etexilate) | Login | BIBR 1087 SE (Desethyl Dabigatran Etexilate) | ||||||||||||||||
|
||||||||||||||||||
| Menthone | Login | Menthone | ||||||||||||||||
|
||||||||||||||||||
| Menthone | Login | Menthone | ||||||||||||||||
|
||||||||||||||||||
| Indatuximab Biosimilar (Anti-Syndecan-1 / CD138 Reference Antibody) | Login | Indatuximab Biosimilar (Anti-Syndecan-1 / CD138 Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Raludotatug Biosimilar(Anti-CDH6 / K-Cadherin Reference Antibody) | Login | Raludotatug Biosimilar(Anti-CDH6 / K-Cadherin Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| BMS patent anti-Integrin α5β1 Biosimilar(Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) | Login | BMS patent anti-Integrin α5β1 Biosimilar(Anti-Integrin a5b1 (ITGA5 & ITGB1) Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Amgen patent anti-beta amyloid Biosimilar(Anti-Amyloid Beta Reference Antibody ) | Login | Amgen patent anti-beta amyloid Biosimilar(Anti-Amyloid Beta Reference Antibody ) | ||||||||||||||||
|
||||||||||||||||||
| Amatuximab Biosimilar(Anti-Mesothelin Reference Antibody) | Login | Amatuximab Biosimilar(Anti-Mesothelin Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| BMS-986148 Biosimilar(Anti-Mesothelin Reference Antibody) | Login | BMS-986148 Biosimilar(Anti-Mesothelin Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Anetumab Biosimilar(Anti-Mesothelin Reference Antibody) | Login | Anetumab Biosimilar(Anti-Mesothelin Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| NIH patent anti-Mesothelin Biosimilar(Anti-Mesothelin Reference Antibody) | Login | NIH patent anti-Mesothelin Biosimilar(Anti-Mesothelin Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Radretumab Biosimilar(Anti-Fibronectin Reference Antibody) | Login | Radretumab Biosimilar(Anti-Fibronectin Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| L19-TNF Biosimilar(Anti-Fibronectin Reference Antibody) | Login | L19-TNF Biosimilar(Anti-Fibronectin Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Oxford Bio patent anti-Matriptase Biosimilar(Anti-Matriptase Reference Antibody) | Login | Oxford Bio patent anti-Matriptase Biosimilar(Anti-Matriptase Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||
| Codrituzumab Biosimilar(Anti-GPC3 / Glypican-3 Reference Antibody) | Login | Codrituzumab Biosimilar(Anti-GPC3 / Glypican-3 Reference Antibody) | ||||||||||||||||
|
||||||||||||||||||


